These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25075216)

  • 21. An Open Access Database of Licensed Cancer Drugs.
    Pantziarka P; Capistrano I R; De Potter A; Vandeborne L; Bouche G
    Front Pharmacol; 2021; 12():627574. PubMed ID: 33776770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repurposing as a potential source of innovative therapies in cervical cancer.
    Capistrano I R; Paul S; Boere I; Pantziarka P; Chopra S; Nout RA; Bouche G
    Int J Gynecol Cancer; 2022 Sep; 32(11):1377-86. PubMed ID: 36137575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.
    Van Nuffel AM; Sukhatme V; Pantziarka P; Meheus L; Sukhatme VP; Bouche G
    Ecancermedicalscience; 2015; 9():513. PubMed ID: 25729426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities.
    Cousins HC; Nayar G; Altman RB
    Annu Rev Biomed Data Sci; 2024 Aug; 7(1):15-29. PubMed ID: 38598857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Pfab C; Schnobrich L; Eldnasoury S; Gessner A; El-Najjar N
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repurposing in oncology--patient and health systems opportunities.
    Bertolini F; Sukhatme VP; Bouche G
    Nat Rev Clin Oncol; 2015 Dec; 12(12):732-42. PubMed ID: 26483297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Curr Med Chem; 2021; 28(11):2137-2174. PubMed ID: 32895037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing Drugs for Skin Cancer.
    Khachigian LM
    Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Dopamine in Repurposing Drugs for Oncology.
    Moura C; Vale N
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repurposing in pediatrics and pediatric hematology oncology.
    Blatt J; Corey SJ
    Drug Discov Today; 2013 Jan; 18(1-2):4-10. PubMed ID: 22835502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.
    Polamreddy P; Gattu N
    Drug Discov Today; 2019 Mar; 24(3):789-795. PubMed ID: 30513339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.
    Allarakhia M
    Drug Des Devel Ther; 2013; 7():753-66. PubMed ID: 23966771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
    Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
    Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
    Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
    JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
    Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.